Your browser doesn't support javascript.
loading
What are the observed procedural costs of vascular access surgery? Protocol for a systematic review.
Edgar, Ben; Jones, Catrin; Aitken, Emma; Stevenson, Karen; Jackson, Andrew; Gaianu, Lucian; Thomson, Peter; Kasthuri, Ram; Stove, Callum; Kingsmore, David.
Affiliation
  • Edgar B; Renal Transplant and Vascular Access Surgery, Queen Elizabeth University Hospital, Glasgow, UK benjamin.edgar@nhs.scot.
  • Jones C; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Aitken E; Renal Transplant and Vascular Access Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
  • Stevenson K; School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Jackson A; Renal Transplant and Vascular Access Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
  • Gaianu L; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
  • Thomson P; Renal Transplant and Vascular Access Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
  • Kasthuri R; Renal Transplant and Vascular Access Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
  • Stove C; Independent Health Economist, Healthonomics UK Ltd, Reading, UK.
  • Kingsmore D; Department of Renal Medicine, Queen Elizabeth University Hospital, Glasgow, UK.
BMJ Open ; 14(1): e079773, 2024 01 25.
Article in En | MEDLINE | ID: mdl-38272545
ABSTRACT

INTRODUCTION:

A central component in the introduction of a novel surgical procedure or technique is an evaluation of its cost efficiency when compared with a benchmark standard of care. Accurate assessment of costs is thus essential in ensuring appropriate allocation of resources within a healthcare system. The treatment of kidney failure requires a significant volume of resources, and vascular access provision is the main modifiable cost. The costs of providing this service are obscured by generic NHS reference costs, which lack adequate granularity to allow meaningful comparisons between treatments. The aim of this systematic review will be to assess the reporting of procedural costs in all published economic analyses of vascular access surgery and perform a comparison of the reported procedural costs involved in arteriovenous fistula (AVF) and arteriovenous graft (AVG) creation. This will provide an estimate as to the accuracy of the NHS reference costs in this field. METHODS AND

ANALYSIS:

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines will be followed. A systematic search will be performed of the MEDLINE, Embase and Cochrane databases to identify full-text economic analyses of vascular access for haemodialysis in which the procedural cost of AVF or AVG creation is reported. Publications in English from 1 January 2000 to 30 August 2023, will be eligible for inclusion. Studies will be selected by title and abstract review, followed by a full-text review using inclusion and exclusion criteria. Studies not reporting the procedural costs of surgery will be excluded. Data collected will pertain to procedural costs of AVF and AVG creation. Costs will be adjusted to a common currency using a gross domestic product (GDP) deflator index and conversion rates based on purchasing power parities for GDP. Comparison with NHS reference costs will indicate their reliability for use in future economic analyses in this field. ETHICS AND DISSEMINATION Ethical approval is not required for this systematic review. Findings will be disseminated through peer-reviewed publications and conference presentations. PROSPERO REGISTRATION NUMBER CRD42023458779.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arteriovenous Shunt, Surgical / Arteriovenous Fistula Type of study: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspects: Ethics Limits: Humans Language: En Journal: BMJ Open Year: 2024 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arteriovenous Shunt, Surgical / Arteriovenous Fistula Type of study: Guideline / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspects: Ethics Limits: Humans Language: En Journal: BMJ Open Year: 2024 Document type: Article Country of publication: United kingdom